Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dipeptidyl peptidase IV inhibitors for the treatment of schizophrenia and depression

Dipeptidyl peptidase IV inhibitors for the treatment of schizophrenia and depression

US Patent 8168199 · Granted May 1, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of meprin α and β2025
Anti-isoAsp7 amyloid β (Aβ) antibodies and uses thereof2023
Bacterial glutaminyl cyclases and inhibitors thereof for use in the treatment of2021
Inhibitors of meprin α and β2021
Heteroaryl SYK inhibitors2021
Pyrazolyl-substituted heteroaryls and their use as medicaments2018
Heteroaryl Syk inhibitors2018
Pyrazolyl-substituted heteroaryls and their use as medicaments2017
Uses of antibodies directed against amyloid-β2017
Diagnostic antibody assay2017
Inhibitors2017
Radiolabelled glutaminyl cyclase (QC) inhibitors and uses of same2017